FindTrial
Sign In

Tianjin Implant-Based Breast Reconstruction (TIMBRE) Cohort

Retrospective study of complications and patient-reported outcomes of Tianjin Implant-Based Breast Reconstruction (TIMBRE) Cohort

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035318
Enrollment
Unknown
Registered
2020-08-08
Start date
2020-08-08
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

surgical area infection group vs non infection group:N/A

Sponsors

Cancer Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Female patients over 18 years old. 2. Patients who underwent total mastectomy and immediate or delayed implant breast reconstruction due to benign or malignant breast lesions.

Exclusion criteria

Exclusion criteria: 1. Patients with metastatic breast cancer; 2. Patients with breast reconstruction with autologous tissue.

Design outcomes

Primary

MeasureTime frame
Complications within 30 days after surgery;Delayed complication rate;Rate of implant failure;Patient-reported outcome;—

Countries

China

Contacts

Public ContactJian Yin

Cancer Hospital of Tianjin Medical University

healthyin2018@163.com+86 22-23340123-1171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026